A pilot study on area under curve of mycophenolic acid as a guide for its optimal use in renal transplant recipients

Abstract

The present findings suggest the MPA AUC of 30 - 60 mg.h/l in the maintenance stage of renal transplant patients to have optimum clinical benefit and relegated adverse events profile indicating the usefulness of AUC of MPA with limited sampling strategy in optimizing its use.